In this article, we will take a look at the 12 stocks that will double in 2025.
We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...
Insider Monkey on MSN11d
Why ImmunityBio, Inc. (IBRX) Dominated Last Week’s RallyWe recently compiled a list of the These 10 Firms Dominated Last Week's Rally. In this article, we are going to take a look ...
Mutual Advisors LLC bought a new position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...
We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a ...
Trump’s attempt to block previously approved Congressional funding not only threatens social programs that benefit millions, ...
ImmunityBio (IBRX) announced the European Medicines Agency has accepted for review and begun assessing the marketing authorization application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback